공시 • May 06
IMCD N.V. to Report Q1, 2027 Results on Apr 29, 2027 IMCD N.V. announced that they will report Q1, 2027 results on Apr 29, 2027 공시 • May 03
IMCD N.V. Approves Cash Dividend, Payable on 8 May 2026 IMCD N.V., at the AGM held on April 30, 2026 approved cash dividend of EUR 1.81 per share. Ex-dividend date is 5 May 2026. Dividend record date is 6 May 2026. Dividend payment date is 8 May 2026. 공시 • Feb 21
IMCD N.V. (ENXTAM:IMCD) signed an agreement to acquire Willows Ingredients Group Limited. IMCD N.V. (ENXTAM:IMCD) signed an agreement to acquire Willows Ingredients Group Limited on February 20, 2026. Through the integration of Willows Ingredients’ supplier partnerships, IMCD will broaden its portfolio and market access to customers throughout Ireland and the UK.
The transaction is subject to customary closing conditions and is expected to close in the first quarter of 2026. 공시 • Feb 18
IMCD N.V. Proposes Dividend for the Year 2025 IMCD N.V. proposed dividend of EUR 1.81 in cash per share (2024: EUR 2.15) for the year 2025. 공시 • Dec 13
IMCD N.V. Announces Chief Financial Officer Changes IMCD N.V. announced that its Supervisory Board nominates Floris Lagerwerf to become Chief Financial Officer (CFO) of IMCD as of January 2027. Floris will succeed Hans Kooijmans, who has decided to retire as per the end of December 2026. Floris started his career as external auditor in 2006, and he joined IMCD in its Rotterdam headquarters in 2016 as Group Controller. In 2021 he became Finance & Operations Director at IMCD Switzerland, and since January 2023, serves as Vice-President Finance & Operations for the Americas region. As of January 1, 2026, Floris will be Vice-President Finance & Operations EMEA and Industrial Business Groups. Hans Kooijmans will remain CFO of IMCD until the end of 2026 and will support Floris towards the transition in 2027. 공시 • Oct 17
IMCD N.V. (ENXTAM:IMCD) signed an agreement to acquire Dong Yang FT Corp. IMCD N.V. (ENXTAM:IMCD) signed an agreement to acquire Dong Yang FT Corp. on October 16, 2025. For the period ending December 31, 2024, Dong Yang FT Corp. reported total revenue of KRW 55.3 billion. The transaction is subject to customary (regulatory) closing conditions and is expected to close in the first quarter of 2026. 공시 • Aug 27
IMCD N.V. (ENXTAM:IMCD) signed an agreement to acquire Tillmanns Spa. IMCD N.V. (ENXTAM:IMCD) signed an agreement to acquire Tillmanns Spa on August 27, 2025.
In 2024, Tillmanns reported annual revenues of ca. €143 million.
The transaction is subject to customary (regulatory) closing conditions and is expected to close in the fourth quarter of 2025.
Domenico Colella and Pietro Masi of Orsingher Ortu Avvocati Associati acted as legal advisor for IMCD N.V. (ENXTAM:IMCD). Ethica Holding S.p.A. acted as financial advisor for the shareholders of Tillmanns Spa. Massimo Di Terlizzi, Graziana Toscano, Giorgio Recine, and Costanza Ceruti of Studio Pirola Pennuto Zei & Associati acted as legal advisor for the shareholders of Tillmanns Spa. For strategic and tax matters, Tillmanns and its partner were supported by Stefano Cesati of Studio Pirola Pennuto Zei & Associati. 공시 • Jul 31
IMCD N.V., Annual General Meeting, Apr 30, 2026 IMCD N.V., Annual General Meeting, Apr 30, 2026. 공시 • Jun 30
IMCD N.V. (ENXTAM:IMCD) agreed to acquire Apus Química SpA. IMCD N.V. (ENXTAM:IMCD) agreed to acquire Apus Química SpA on June 30, 2025. The terms of the transaction are undisclosed.
For the period ending December 31, 2024, Apus Química SpA reported total revenue of approximately €15 million.
The transaction is subject to customary closing conditions and is expected to close in July 2025. 공시 • Jun 06
IMCD N.V. (ENXTAM:IMCD) signed an agreement to acquire Ferrer Alimentacion Sa. IMCD N.V. (ENXTAM:IMCD) signed an agreement to acquire Ferrer Alimentacion Sa on June 6, 2025.
For the period ending December 31, 2024, Ferrer Alimentacion Sa reported total revenue of €112 million.
The transaction is subject to customary closing conditions and is expected to close in June 2025. 공시 • Mar 06
IMCD N.V. announces Annual dividend, payable on May 06, 2025 IMCD N.V. announced Annual dividend of EUR 2.1500 per share payable on May 06, 2025, ex-date on April 29, 2025 and record date on April 30, 2025. 공시 • Nov 14
IMCD N.V. has filed a Follow-on Equity Offering in the amount of €300 million. IMCD N.V. has filed a Follow-on Equity Offering in the amount of €300 million.
Security Name: Ordinary Shares
Security Type: Common Stock 공시 • Oct 17
IMCD N.V. (ENXTAM:IMCD) agreed to acquire Blumos Group. IMCD N.V. (ENXTAM:IMCD) has signed an agreement to acquire Blumos Group on October 17, 2024.
The transaction is subject to customary regulatory closing conditions. The expected completion of the transaction is in the fourth quarter of 2024. 공시 • Aug 03
IMCD N.V., Annual General Meeting, Apr 25, 2025 IMCD N.V., Annual General Meeting, Apr 25, 2025. 공시 • May 16
IMCD N.V. Approves Dividend for the Year 2023, Payable on 21 May 2024 IMCD N.V. announced that at its AGM held on May 14, 2024, approved the dividend proposal of EUR 2.24 per share in cash. Ex-dividend date is on 16 May 2024. Dividend record date is on 17 May 2024. Dividend payment date is on 21 May 2024. 공시 • Jan 10
IMCD N.V. (ENXTAM:IMCD) acquired 70% stake in Valuetree Ingredients Private Limited from the founders of Valuetree Ingredients Private Limited. IMCD N.V. (ENXTAM:IMCD) acquired 70% stake in Valuetree Ingredients Private Limited from the founders of Valuetree Ingredients Private Limited on January 10, 2024. IMCD N.V. (ENXTAM:IMCD) will acquire the remaining 30% stake in Valuetree Ingredients Private Limited in 2025. The founders of Valuetree will continue to lead the company post-completion of this first tranche. For the financial year ended on March 31, 2023 Valuetree Ingredients Private Limited generated revenue of approximately INR 4.4 billion. IMCD N.V. (ENXTAM:IMCD) completed the acquisition of 70% stake in Valuetree Ingredients Private Limited from the founders of Valuetree Ingredients Private Limited on January 10, 2024. 공시 • Nov 30
IMCD Appoints Dorthe Mikkelsen as Member of the Supervisory Board IMCD N.V. announced that Mrs. Dorthe Mikkelsen has been appointed as member of the Supervisory Board at the Extraordinary General Meeting of IMCD N.V. held on 27 November 2023. 공시 • Aug 02
IMCD N.V. (ENXTAM:IMCD) signed an agreement to acquire Sachs Chemical, Inc. IMCD N.V. (ENXTAM:IMCD) signed an agreement to acquire Sachs Chemical, Inc. on August 1, 2023. Sachs Chemical, Inc. generated a revenue of approximately $50 million in 2022. IMCD welcomes Sachs’ 38 employees to its local organization. The closing of the transaction is subject to customary closing conditions and is expected to take place in August 2023. 공시 • Jun 17
IMCD N.V. (ENXTAM:IMCD) agreed to acquire Brylchem Group. IMCD N.V. (ENXTAM:IMCD) agreed to acquire Brylchem Group on June 16, 2023. IMCD will acquire Brylchem Pte Ltd, Chemipac Pte Ltd, and CMS Marketing Trading Co., Ltd. Brylchem Group achieved a revenue of approximately SGD 85 million in 2022. The transaction is expected to be completed in the fourth quarter of 2023, subject to customary closing conditions. New Risk • Jun 08
New minor risk - Dividend sustainability The company has an unstable dividend paying track record. The dividend has had an annual drop of over 20% in the past. Dividend yield: 1.7% This is considered a minor risk. If the company has cut or reduced its dividend in the past, it may be a sign that the underlying business is too cyclical to consistently maintain or grow the dividend over the long-term. It may also indicate the company prioritizes other outcomes instead of maintaining the dividend. For dividend paying companies, any reduction in the dividend can significantly impact the share price. Currently, the following risks have been identified for the company: Minor Risks High level of debt (56% net debt to equity). Unstable dividend paying track record with dividend experiencing an annual drop of over 20% in the past. 공시 • May 19
IMCD N.V. (ENXTAM:IMCD) signed an agreement to acquire Euro Chemo-Pharma Sdn. Bhd. IMCD N.V. (ENXTAM:IMCD) signed an agreement to acquire Euro Chemo-Pharma Sdn. Bhd. on May 19, 2023. In this transaction, IMCD will also acquire Euro Chemo-Pharma's wholly owned subsidiary, Biofresh Green Sdn Bhd. Euro Chemo-Pharma has reported revenue of approximately MYR 270 million during financial year ended on June 30, 2022. The closing of the transaction is subject to customary closing conditions. The transaction is expected to take place in the last quarter of 2023. 공시 • May 06
IMCD N.V. (ENXTAM:IMCD) signed an agreement to acquire Koi Products Solutions & Engineering Ltd. IMCD N.V. (ENXTAM:IMCD) signed an agreement to acquire Koi Products Solutions & Engineering Ltd on May 5, 2023. KOI Products has generated a revenue of above €8 million in financial year 2022 and adds 13 employees to the IMCD Israel team. The closing of the transaction is subject to customary closing conditions and is expected to take place in June 2023. 공시 • Feb 17
IMCD N.V. (ENXTAM:IMCD) signed an agreement to acquire CPS Chemical Oil-Tech (Pty) Ltd. IMCD N.V. (ENXTAM:IMCD) signed an agreement to acquire CPS Chemical Oil-Tech (Pty) Ltd on February 16, 2023. CPS Oil-Tech generated a revenue of approximately ZAR 228 million in the financial year that ended on February 28, 2022. The company represents leading global suppliers and serves a large group of customers with an extensive portfolio of products alongside commercial and technical support. Joining forces with CPS Oil-Tech will enable IMCD South Africa to offer its customers an increased product offering, through the valued strategic principals that CPS Oil-Tech, already represents. The closing of the transaction is subject to customary closing conditions and regulatory approval and is expected to take place in the second quarter of 2023. 공시 • Oct 11
IMCD N.V. to Report First Half, 2023 Results on Aug 04, 2023 IMCD N.V. announced that they will report first half, 2023 results on Aug 04, 2023